InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Camp4 Therapeutics Corp

CAMP Clue Score56
United States Fiscal year ends December CIK 0001736730
$3.77 +1.89% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.77 −0.53% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 11 Oct 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2023Revenue0.4Operating income−51.9Net income−49.3EPS, diluted−124.80Fiscal year 2024Revenue0.7 +86.3%Operating income−53.1Net income−51.8EPS, diluted−11.04Fiscal year 2025Revenue3.5 +436.5%Operating income−52.6Net income−80.4EPS, diluted−2.65
FY2023FY2024FY2025
Revenue 0.4 0.7 3.5
Growth +86.3% +436.5%
Operating income −51.9 −53.1 −52.6
Net income −49.3 −51.8 −80.4
Growth
EPS, diluted −124.80 −11.04 −2.65

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2023Operating margin−14,822.6%Net margin−14,083.1%Free cash flow margin−12,809.4%Fiscal year 2024Operating margin−8,142.3%Net margin−7,943.4%Free cash flow margin−7,055.7%Fiscal year 2025Operating margin−1,502.4%Net margin−2,298.5%Free cash flow margin−852.8%
FY2023FY2024FY2025
Operating margin −14,822.6% −8,142.3% −1,502.4%
Net margin −14,083.1% −7,943.4% −2,298.5%
Free cash flow margin −12,809.4% −7,055.7% −852.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2023Operating cash flow−44.2Capital expenditure−0.7Free cash flow−44.8Fiscal year 2024Operating cash flow−45.6Capital expenditure−0.4Free cash flow−46.0Fiscal year 2025Operating cash flow−29.6Capital expenditure−0.3Free cash flow−29.8
FY2023FY2024FY2025
Operating cash flow −44.2 −45.6 −29.6
Capital expenditure −0.7 −0.4 −0.3
Free cash flow −44.8 −46.0 −29.8
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2023Cash38.4Shareholders’ equity−123.7Fiscal year 2024Cash64.0Shareholders’ equity63.1Fiscal year 2025Cash109.5Shareholders’ equity47.7
FY2023FY2024FY2025
Cash 38.4 64.0 109.5
Shareholders’ equity −123.7 63.1 47.7

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
−14,822.6% −8,142.3% −1,502.4%
−14,083.1% −7,943.4% −2,298.5%
−12,809.4% −7,055.7% −852.8%
Spending
11,604.6% 5,953.5% 1,092.1%
3,318.0% 2,288.8% 496.2%
193.7% 67.6% 8.0%
Returns
n/a −82.0% −168.5%
−89.7% −66.1% −68.2%
Balance and payout
30.1% 19.4% 59.5%